Ongoing research project details:
S.No. | Title of the project | Funding agency |
Industry Sponsored | |
1 | EON’s DINI (Diet-Infection-Nutrition-Immunity) Axis approach – Proof of Concept: Immunomodulatory Nutritional Intervention for CRC Management (PI) | EON1*(May, 2021 - May, 2023) |
Government funding | |
2 | Glucocorticoid receptor (GR)-targeted liposomal nano-platform for drug sensitization, EMT reversal toward effective treatment of aggressive oral cancer (Multi-Institutional Grant: PI) | DBT2&3* (Nov, 2022 - Nov, 2025) |
3. | Antibacterial, host-modulating and regenerative nanofibers membrane for guided tissue regeneration (Multi-Institutional Grant: PI) | DBT4* (Dec, 2022 - Dec, 2025) |
4. | "CRISPR mediated genetic correction of Sickle Cell disease towards clinical trials in a small patient cohort” (Multi-Institutional Grant: as collaborator with CSIR-IICT) | DST2* |
PI of research funding for fellowship | |
5. | Folate receptor mediated targeting of Oral Cancer: therapeutics and mechanistic investigation of tumor regression (PI). | ICMR-SRF Project |
6. | Investigating the role of GR mediated liposomal delivery system against OSCC and Tumor Microenvironment for targeted therapeutics (PI) | JRF-Lady Tata Memorial Trust Award (August 2022) |
In house (BITS funded project) |
7. | OC3-Centre for Human Diseases Research (CHDR), Test the efficacy of SHR-mediated drug delivery system for oral cancer. |
*Collaborators:
1. Industrial collaborator: Dr. Anubhab Mukherjee, Principal Scientist, Esperer Onco Nutrition, Mumbai
2. Dr. Rajkumar Banerjee (CSIR-IICT, Hyderabad)
3. Dr. Madhusudan Rao Gummanur, (ACDS, Secunderabad).
4. Dr. Jyotsnendu Giri, (IIT, Hyderabad)
5. Dr. Venkata Srilakshmi P (NIT, Warangal)
Completed research project details:
1 | Screening of steroid hormone receptors and their ligands for targeted delivery of cationic liposome in cancer cells, Research Initiation Grant funded by BITS Pilani (PI). |
2 | Development of personalized DNA markers in breast cancer patients for early diagnosis and prognosis using a non -invasive method. Seed Grant funded by BITS Pilani. (Co-PI) |
3 | Transgenic Embryonic stem cell models for studying the role of elevated levels of DNMT1 and DNMT3A in neuropsychiatric disorders funded by DBT, India. (Co-PI) |
Acknowledgment:
I thank Director, BITS Pilani Hyderabad Campus for providing fund through CHDR. I also thank DBT, DST, ICMR, EON & Lady Tata Memorial Trust for sponsoring research grant/ fellowship. I sincerely thank my collaborators and highly appreciate their support in running our collaborative grants.